| High degree of agreement | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 
      
        | Non-modifiable    risk factors | 
      
        | Personal    and family medical history | √ | √ | √ | √ | √ | √ | √ | √ | 
      
        | Modifiable    risk factors | 
      
        | Blood pressure/pulse | √ |  | √ | √ | √ | √ | √ | √ | 
      
        | Body Mass Index | √ |  | √ | √ | √ | √ | √ | √ | 
      
        | Glucose levels | √ | √ | √ | √ | √ | √ | √ | √ | 
      
        | Lipid levels | √ |  | √ | √ | √ | √ | √ | √ | 
      
        | Weight | √ | √ | √ | √ | √ | √ | √ | √ | 
    
      
        |  | 
      
        | Medium degree of agreement | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 
      
        | Modifiable    risk factors | 
      
        | Drug use | √ | √ | √ |  |  | √ | √ | √ | 
      
        | Electrocardiogram |  | √ | √ |  |  | √ | √ | √ | 
      
        | Extrapyramidal symptoms,    dyskinesia or other side effects |  | √ | √ |  | √ | √ | √ | √ | 
      
        | Height | √ |  | √ |  |  | √ | √ | √ | 
      
        | Lifestyle (diet, exercise,    etc.) | √ |  | √ | √ |  | √ | √ |  | 
      
        | Sexual dysfunction |  |  | √ | √ |  |  | √ | √ | 
      
        | Waist circumference | √ |  | √ | √ | √ | √ |  | √ | 
    
      
        |  | 
      
        | Low degree of agreement | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 
      
        | Modifiable    risk factors | 
      
        | Blood count |  | √ |  |  |  |  | √ | √ | 
      
        | Hepatic function |  |  | √ |  |  | √ |  |  | 
      
        | Magnetic resonance imaging or    tomography |  |  |  |  |  |  | √ |  | 
      
        | Mammography/prostate specific    antigen |  |  |  |  |  |  | √ |  | 
      
        | Menstruation |  |  |  | √ |  |  |  |  | 
      
        | Neurological and motor    disorder |  |  |  |  |  |  | √ |  | 
      
        | Physical examination (dental    health, ocular health, etc.) |  | √ |  |  |  |  | √ | √ | 
      
        | Pregnancy test |  |  |  |  |  |  | √ |  | 
      
        | Prolactin |  |  | √ | √ |  |  |  | √ | 
      
        | Renal function |  |  |  |  |  | √ |  | √ | 
      
        | Sedation |  |  | √ |  |  |  |  |  | 
      
        | Serology |  |  |  |  |  |  | √ | √ | 
      
        | Sexual risk behavior |  |  |  |  |  |  | √ | √ | 
      
        | Thyroid function |  |  | √ |  |  | √ |  | √ | 
      
        | Urine/biochemistry |  |  | √ |  |  |  | √ |  | 
    
      1 = Barnett; 2 = British Association of Psychopharmacology; 3 = British Association
    of Psychopharmacology; 4 = Heald; 5 = Ministry of Health Clinical Practice Guidelines
    Workgroup on Schizophrenia; 6 = NICE; 7 = Working Group of the Clinical
    Practice Guideline for Schizophrenia and Incipient Psychosis Disorder; 8 = Working
    Group on the Physical Health of Patients with Schizophrenia